Researchers from the Centre for control and prevention of diseases of the USA have developed a fast test to identify a person of hepatitis C. To date, worldwide, 150 million people have hepatitis C. the Disease is amenable to effective treatment only in the early stages. Often to help the difficult patient due to late presentation to the doctors. Then, cirrhosis, fibrosis or even liver cancer, says NDTV.
Today the identification of hepatitis C is carried out in two stages. First is the detection of antibodies in human blood. Further infection check on the activity. Scientists at UCLA believe there is a quicker way to diagnose.
The new test uses as biological material a sample of urine. The patient is not required to donate blood, which simplifies the procedure. Preliminary studies prove the effectiveness of the method, its high sensitivity and specificity.